stp_bannerlogocombo twitter facebook employee contact

Synergy Therapeutic Partners (STP) is a premier multi-centered clinical research organization that conducts highly efficient clinical trials for the pharmaceutical industry. "Our Vision is to provide best practices in clinical research for the advancement of modern day medicine." Our staff has a combined experience of 15 years offering the "We Care" attitude to our patients and stakeholders. We are committed to serving our communities with best practices and innovating ideas that will positively impact the medical industry.

Welcome to Synergy Therapeutic Partners

"Today’s Standard Treatment was Yesterday’s Clinical Trial"

Synergy Therapeutic Partners (STP) provides efficient and high quality Phase II, III, IV, and over-the-counter clinical trials to the pharmaceutical industry.  Our staff is committed to the advancement of modern medicine by providing our clients with reliable and expeditious services.  We serve as the connecting force in meeting and exceeding expectations in patient recruitment and regulatory processing.

lg_test_tubes

STP is committed to making clinical trials accessible across diverse populations and providing patients with optimal care.  We ensure each patient is well-informed about the clinical research process. Please feel free to view the FAQs to learn more about participating in a clinical trial.   

FDA Drug Info Rounds
Drug Name Review
FDA Drug Info Rounds pharmacists discuss FDA's ...

Communicating Benefit and ...
FDA Drug Info Rounds pharmacists talk about the ...

Communicating Drug Safety ...
FDA Drug Info Rounds pharmacists discuss the ...

Drug Shortages Video
FDA Drug Info Rounds pharmacists discuss FDA's ...

Evamist Video
FDA Drug Info Rounds pharmacists discuss FDA's ...

Proton Pump Inhibitors (PPIs) ...
FDA Drug Info Rounds pharmacists discuss new ...

Long-Acting Beta-Agonists ...
Long-Acting Beta-Agonists (LABAs), a class of ...

Single-Ingredient Oral ...
FDA Drug Info Rounds pharmacists discuss the ...

NIH News Releases
Umbilical cord ‘milking’ ...
For preemies delivered by C-section, technique ...

NIH begins clinical trial of ...
Study will assess the safety and efficacy of ...

UPDATE: NIH provides interim ...
Plan outlines aggressive timeline to achieve key ...

NIH Council of Councils ...
New members will serve terms through October 2017.

Researchers design ...
NIH team and colleagues believe microdevice may ...

Study of Ebola survivors ...
Trial to examine long-term health effects of ...

Panel urges innovative ...
Panel calls for more research and more ...

Study may help Department of ...
Scientists were able to identify small groups of ...

NIH approves strategic vision ...
Vision positions NLM as unifying force in ...

NIH Common Fund launches ...
Program aims to identify molecules that ...

NIH Names Walter J. ...
He has served as Acting Director of the NINDS ...

Health Disparities in U.S. ...
According the American Journal of Public Health ...

A new role for zebrafish: ...
Such large scale gene targeting in an animal ...

NIH suspends operations in ...
A series of deficiencies require closure to ...

NIH researchers pilot ...
Findings indicate 3 percent or more of the U.S. ...

NIH study finds alcohol use ...
AUDs often untreated.

NIH to host telebriefing to ...
Panel will hold a press telebriefing to discuss ...

NCI-MATCH trial will link ...
Study to examine targeted therapies for tumors ...

Antibiotic approved for ...
NIH-funded study evaluated meropenem in children ...

A patient’s budding cortex ...
Networking neurons thrive in 3-D human "organoid".

Nearly 1 in 7 Hispanic/Latino ...
NIH-funded research points to factors related to ...